Levonorgestrel-releasing intrauterine devices [2] (multiple letters)

Lancet

Volumn 357, Issue 9258, 2001, Pages 801-

  Cohen, Ilan ^a   Gerber, Bernd ^b   Reimer, Toralf ^b   Krause, Annette ^b   Friese, Klaus ^b   Müller, Heiner ^b  

^a Sapil Medical Centre   (Israel)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GESTAGEN; LEVONORGESTREL; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; PROGESTERONE DERIVATIVE;

BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HYSTEROSCOPE; INTRAUTERINE CONTRACEPTIVE DEVICE; LETTER; LONG TERM EXPOSURE; POSTMENOPAUSE; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME; UTERUS DISEASE; AGED; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENDOMETRIUM; MIDDLE AGED; NOTE; PATHOLOGY;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE CONGENERS; TAMOXIFEN;

EID: 0035836122     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71222-8     Document Type: Letter

References (5)

1. FJE Gardner JC Konje KR Abrams Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomized controlled trial Lancet 356 2000 1711 1717
2. LE Gibson RR Barakat ES Venkatraman Endometrial changes at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers Cancer J 2 1996 35 38
3. LE Hann CS Geiss AM Bach Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings Am J Radiol 168 1997 657 661
4. I Cohen E Perel D Flex Endometrial pathologies in postmenopausal tamoxifen treatment: comparison between gynecologically symptomatic and asymptomatic breast cancer patients J Clin Pathol 52 1999 278 282
5. PG Rose EV Brandewie FW Abdul-Karim Failure of megestrol acetate to reverse tamoxifen induced endometrial neoplasia: two case reports Int J Gynecol Cancer 9 1999 362 364